ALLERGAN AESTHETICS
LIVE

Serial Number

88821482

Owner

Allergan, Inc.

Attorney

Matthew O. Brady

First Use Date

Jan 16, 2020

Filing Date

Mar 4, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ALLERGAN AESTHETICS Trademark

Serial Number: 88821482 • Registration: 6969502

ALLERGAN AESTHETICS is a trademark filed by Allergan, Inc. on March 4, 2020. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Allergan, Inc. (4 trademarks)

1 N. Waukegan Road
North Chicago, IL 60064

Entity Type: 03

Trademark Details

Filing Date

March 4, 2020

Registration Date

January 31, 2023

First Use Anywhere

January 16, 2020

First Use in Commerce

May 8, 2020

Published for Opposition

June 30, 2020

Goods & Services

House mark used for a line of pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics; anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations, namely, anti-inflammatories, anti-infectives, anti-glacuoma pharmaceutical preparations for the treatment of glaucoma, and decongestants; pharmaceutical preparations to treat and prevent glaucoma; ocular wetting solutions, namely, eye drops, artificial tears and gels as pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting sensory organs; Antibiotics; Antifungal preparations; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, serums, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body; medicated cosmetic skin care preparations; Pharmaceutical preparations for reducing localized fat deposits; Pharmaceutical preparations, namely, processed human donor skin for soft tissue regeneration and reconstruction; processed human donor skin for skin replacement; Non-living biological implants comprised of processed acellular porcine mesh for the surgical repair and reinforcement of soft tissues; Pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; biological dermal implants, namely, visco-supplementation solutions for filling wrinkles

Promoting the public awareness of medical aesthetics treatments and procedures through consumer information programs

Consumer education programs, namely, classes and seminars in the field of medical aesthetics treatments and procedures

House mark used for a line of non-medicated cosmetic and skincare preparations; Skin cleansers; Skin toners; Facial skin lotions; Skin moisturizers; Anti-aging moisturizers; Skin creams and beauty serums; Anti-aging creams; Eye creams and beauty serums; Anti-wrinkle creams; hair texture cream and hair texture lotion; firming creams and lotions as cosmetic preparations; After sun creams; Sun damage repair creams; Age-retardant creams as anti-aging cream; Age spot reducing creams; Sunscreens as a type of sunscreen preparation; Exfoliant creams; Chemical skin peeling solutions as a type of non-medicated skin care preparation; body mist as non-medicated skin care preparation; Body sprays; facial mist as non-medicated skin care preparation; facial spray; Beauty masks; Non-medicated cosmetics in the form of skin and face creams, gels, ointments, pastes, foams, lotions, sprays and waxes for non-medically treating glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin

House mark used for a line of surgical, medical, therapeutic and cosmetic instruments for treating glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for use in facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics, muscle stimulation, body contouring and ophthalmic related diseases and disorders; intra-uterine non-chemical contraceptive devices; medical diagnostic instruments for the analysis of body fluids; Dermatological microdermabrasion apparatus, namely, instruments used for performing microdermabrasion of the skin and which deliver topical solutions to the skin during a procedure; Cosmetic apparatus, namely, an electronic skin treatment device in the nature of a skin-resurfacing treatment device that combines exfoliation, extraction, and infusion of condition-specific serums to improve skin health, function and appearance; Medical devices, namely, apparatus for tissue cooling, body shaping and contouring, and treatment of cellulite and soft tissue; medical devices used to destroy fat cells; Medical devices, namely, therapeutic apparatus and instruments generating high frequency electromagnetic energy for use in muscle stimulation, treatment of cellulite and soft tissue, and sculpting, shaping and contouring of the body; Medical devices, namely, medical apparatus and instruments generating high frequency electromagnetic energy for use in electrical muscle stimulation for medical purposes, treatment of cellulite, and treatment of soft tissue by means of electrical nerve stimulation for medical purposes; Medical devices to facilitate the placement of cosmetic implants during surgical procedures; Cell transfer apparatus, namely, graft harvesting instruments; medical injectors, namely, adipose tissue and medical fluid injectors; Surgical and medical apparatus and instruments for use in processing adipose tissue; Apparatus for the medical treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, namely, needles for the injection of hyaluronic acid formulations for medical purposes

Providing medical information to consumers and healthcare professionals to enhance their understanding of medical aesthetics treatments and procedures

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 6, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 6, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 6, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 6, 2026 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 31, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 31, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 28, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 27, 2022 CNPR
ASSIGNED TO EXAMINER
Nov 1, 2022 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 12, 2022 CRFA
ASSIGNED TO LIE
Oct 12, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 4, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 4, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 4, 2022 GNRT
SU - NON-FINAL ACTION - WRITTEN
Apr 4, 2022 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 25, 2022 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Feb 24, 2022 SUPC
SOU EXTENSION 3 GRANTED
Feb 24, 2022 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 24, 2022 AITU
USE AMENDMENT FILED
Feb 16, 2022 IUAF
SOU EXTENSION 3 FILED
Feb 16, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 16, 2022 EEXT
TEAS STATEMENT OF USE RECEIVED
Feb 16, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 27, 2021 EXRA
SOU EXTENSION 2 GRANTED
Aug 25, 2021 EX2G
SOU EXTENSION 2 FILED
Aug 25, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 25, 2021 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 3, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 3, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 3, 2021 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 22, 2021 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 27, 2021 EXRA
SOU EXTENSION 1 GRANTED
Feb 25, 2021 EX1G
SOU EXTENSION 1 FILED
Feb 25, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 25, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 25, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 30, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 30, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2020 NONP
ASSIGNED TO LIE
May 26, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 14, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
May 13, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 13, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
May 13, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 13, 2020 CNEA
EXAMINER'S AMENDMENT ENTERED
May 6, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 6, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
May 6, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 6, 2020 CNEA
ASSIGNED TO EXAMINER
Apr 29, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2020 NWOS
NEW APPLICATION ENTERED
Mar 7, 2020 NWAP